A preliminary study of manipulation under anaesthesia for secondary frozen shoulder following breast cancer treatment.
BACKGROUND
The aim of this paper is to present the results of manipulation under anaesthesia (MUA) and injection of local anaesthetic and corticosteroid followed by a physiotherapy regime for secondary frozen shoulder after breast cancer treatment (surgery, radiotherapy), and to compare them with a control group.


METHODS
Patients referred to the senior author for secondary frozen shoulder following breast cancer treatment over a ten-year period were investigated. Recorded data included age, treatment for breast cancer, length of symptoms, Oxford shoulder score (OSS) and range of motion before and after shoulder MUA. These data were compared with a control group of patients with frozen shoulder.


RESULTS
A total of 263 patients were referred with 281 frozen shoulders. Of these, 7 patients (7 shoulders) had undergone previous breast cancer treatment and the remaining 256 patients (274 shoulders) formed the control group. None of the patients were diabetic. The mean preoperative OSS was 31 for the study group and 27 for the control group, improving to 43 for both groups following MUA. Forty-two per cent of the study group and fifteen per cent of the control group had a second MUA subsequently. At the long-term follow-up appointment, 71% of the study group patients were satisfied with their result.


CONCLUSIONS
The results of this preliminary study suggest that MUA, corticosteroid injection and subsequent physiotherapy have achieved good final results in a series of patients with frozen shoulder secondary to breast cancer treatment. Members of the multidisciplinary team looking after breast cancer patients should be aware of this management option and, on manifestation of this pathology, should refer the patient to an orthopaedic surgeon.
Great Western Hospitals NHS Foundation Trust, UK.
A
A
Leonidou
D A
DA
Woods
D000328:Adult; D000768:Anesthesia, General / Q000379:methods; D000779:Anesthetics, Local / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000150:complications / Q000628:therapy*; D002045:Bupivacaine / Q000008:administration & dosage; D002062:Bursitis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D016022:Case-Control Studies; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005081:Exercise Therapy / Q000379:methods; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D006875:Hydrotherapy / Q000379:methods; D007270:Injections, Intra-Articular; D008349:Manipulation, Orthopedic / Q000379:methods*; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D016059:Range of Motion, Articular / Q000502:physiology; D012189:Retrospective Studies; D012720:Severity of Illness Index
D000779:Anesthetics, Local; D005938:Glucocorticoids; D008775:Methylprednisolone; D002045:Bupivacaine